story of the week
Serum GFAP as a Biomarker for MS Progression
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
JAMA Neurol 2023 Feb 06;[EPub Ahead of Print], S Meier, EAJ Willemse, S Schaedelin, J Oechtering, J Lorscheider, L Melie-Garcia, A Cagol, M Barakovic, R Galbusera, S Subramaniam, C Barro, A Abdelhak, S Thebault, L Achtnichts, P Lalive, S Müller, C Pot, A Salmen, G Disanto, C Zecca, M D'Souza, A Orleth, M Khalil, A Buchmann, R Du Pasquier, Ö Yaldizli, T Derfuss, K Berger, M Hermesdorf, H Wiendl, F Piehl, M Battaglini, U Fischer, L Kappos, C Gobbi, C Granziera, C Bridel, D Leppert, A Maleska Maceski, P Benkert, J KuhleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.